COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia

Alessandro Bertolino, Grazia Caforio, Giuseppe Blasi, Antonio Rampino, Lorenzo Sinibaldi, Sophia Douzgou, Marcello Nardini, Daniel Weinberger, Bruno Dallapiccola

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)253-255
Number of pages3
JournalSchizophrenia Research
Volume95
Issue number1-3
DOIs
StatePublished - Sep 2007
Externally publishedYes

Fingerprint

Schizophrenic Psychology
olanzapine
Psychiatric Status Rating Scales
Catechol O-Methyltransferase
Pharmacogenetics
Valine
Benzodiazepines
Methionine
Antipsychotic Agents
Single Nucleotide Polymorphism
Schizophrenia
Genotype

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Cite this

Bertolino, A., Caforio, G., Blasi, G., Rampino, A., Sinibaldi, L., Douzgou, S., ... Dallapiccola, B. (2007). COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia. Schizophrenia Research, 95(1-3), 253-255. https://doi.org/10.1016/j.schres.2007.06.014

COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia. / Bertolino, Alessandro; Caforio, Grazia; Blasi, Giuseppe; Rampino, Antonio; Sinibaldi, Lorenzo; Douzgou, Sophia; Nardini, Marcello; Weinberger, Daniel; Dallapiccola, Bruno.

In: Schizophrenia Research, Vol. 95, No. 1-3, 09.2007, p. 253-255.

Research output: Contribution to journalLetter

Bertolino, A, Caforio, G, Blasi, G, Rampino, A, Sinibaldi, L, Douzgou, S, Nardini, M, Weinberger, D & Dallapiccola, B 2007, 'COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia', Schizophrenia Research, vol. 95, no. 1-3, pp. 253-255. https://doi.org/10.1016/j.schres.2007.06.014
Bertolino, Alessandro ; Caforio, Grazia ; Blasi, Giuseppe ; Rampino, Antonio ; Sinibaldi, Lorenzo ; Douzgou, Sophia ; Nardini, Marcello ; Weinberger, Daniel ; Dallapiccola, Bruno. / COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia. In: Schizophrenia Research. 2007 ; Vol. 95, No. 1-3. pp. 253-255.
@article{3765e87d712c49e88b8a178de41d93f8,
title = "COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia",
author = "Alessandro Bertolino and Grazia Caforio and Giuseppe Blasi and Antonio Rampino and Lorenzo Sinibaldi and Sophia Douzgou and Marcello Nardini and Daniel Weinberger and Bruno Dallapiccola",
year = "2007",
month = "9",
doi = "10.1016/j.schres.2007.06.014",
language = "English (US)",
volume = "95",
pages = "253--255",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia

AU - Bertolino, Alessandro

AU - Caforio, Grazia

AU - Blasi, Giuseppe

AU - Rampino, Antonio

AU - Sinibaldi, Lorenzo

AU - Douzgou, Sophia

AU - Nardini, Marcello

AU - Weinberger, Daniel

AU - Dallapiccola, Bruno

PY - 2007/9

Y1 - 2007/9

UR - http://www.scopus.com/inward/record.url?scp=34548160606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548160606&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2007.06.014

DO - 10.1016/j.schres.2007.06.014

M3 - Letter

C2 - 17644310

AN - SCOPUS:34548160606

VL - 95

SP - 253

EP - 255

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 1-3

ER -